2024 Q2 Form 10-Q Financial Statement
#000143612624000035 Filed on May 03, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $189.8M | $184.4M |
YoY Change | 7.81% | 9.78% |
Cost Of Revenue | $133.7M | $133.4M |
YoY Change | 5.82% | 9.36% |
Gross Profit | $56.12M | $51.09M |
YoY Change | 12.86% | 10.88% |
Gross Profit Margin | 29.57% | 27.7% |
Selling, General & Admin | $40.96M | $41.19M |
YoY Change | -1.27% | -3.82% |
% of Gross Profit | 72.99% | 80.62% |
Research & Development | $231.0K | $343.0K |
YoY Change | -54.79% | -28.54% |
% of Gross Profit | 0.41% | 0.67% |
Depreciation & Amortization | $8.288M | $2.447M |
YoY Change | -0.25% | -70.91% |
% of Gross Profit | 14.77% | 4.79% |
Operating Expenses | $41.19M | $43.98M |
YoY Change | -1.92% | 1.56% |
Operating Profit | $11.96M | $7.111M |
YoY Change | 207.19% | -488.58% |
Interest Expense | -$4.413M | -$4.430M |
YoY Change | -214.39% | -208.9% |
% of Operating Profit | -36.9% | -62.3% |
Other Income/Expense, Net | ||
YoY Change | ||
Pretax Income | $7.546M | $1.123M |
YoY Change | 21460.0% | -119.04% |
Income Tax | $1.173M | $119.0K |
% Of Pretax Income | 15.54% | 10.6% |
Net Earnings | $6.369M | $995.0K |
YoY Change | 1789.91% | -119.96% |
Net Earnings / Revenue | 3.36% | 0.54% |
Basic Earnings Per Share | $0.03 | |
Diluted Earnings Per Share | $0.20 | $0.03 |
COMMON SHARES | ||
Basic Shares Outstanding | 30.97M shares | 30.63M shares |
Diluted Shares Outstanding | 31.29M shares | 31.36M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $17.18M | $16.86M |
YoY Change | -4.57% | 0.83% |
Cash & Equivalents | $17.18M | $16.86M |
Short-Term Investments | ||
Other Short-Term Assets | $11.38M | $14.63M |
YoY Change | -36.72% | 4.45% |
Inventory | $14.94M | $15.08M |
Prepaid Expenses | ||
Receivables | $150.0M | $140.4M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $193.5M | $187.0M |
YoY Change | 13.25% | 12.69% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $78.79M | $79.70M |
YoY Change | -3.09% | 1.12% |
Goodwill | $185.0M | $185.7M |
YoY Change | -8.23% | -7.12% |
Intangibles | $41.71M | $42.66M |
YoY Change | -9.61% | -9.92% |
Long-Term Investments | ||
YoY Change | ||
Other Assets | $45.54M | $47.07M |
YoY Change | 13.36% | 22.42% |
Total Long-Term Assets | $354.7M | $355.2M |
YoY Change | -4.17% | -2.67% |
TOTAL ASSETS | ||
Total Short-Term Assets | $193.5M | $187.0M |
Total Long-Term Assets | $354.7M | $355.2M |
Total Assets | $548.1M | $542.1M |
YoY Change | 1.33% | 2.13% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $13.76M | $15.63M |
YoY Change | -19.13% | 14.58% |
Accrued Expenses | $85.73M | $84.48M |
YoY Change | 22.97% | 24.47% |
Deferred Revenue | $8.296M | $9.244M |
YoY Change | -10.38% | -0.14% |
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $10.02M | $14.37M |
YoY Change | 32.73% | 94.94% |
Total Short-Term Liabilities | $114.5M | $114.9M |
YoY Change | 4.41% | 11.29% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $189.7M | $200.1M |
YoY Change | 7.71% | 9.97% |
Other Long-Term Liabilities | $37.00M | $36.98M |
YoY Change | 15.47% | 21.53% |
Total Long-Term Liabilities | $226.7M | $237.1M |
YoY Change | 8.9% | 11.63% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $114.5M | $114.9M |
Total Long-Term Liabilities | $226.7M | $237.1M |
Total Liabilities | $354.7M | $355.0M |
YoY Change | 4.19% | 6.07% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$21.58M | -$27.95M |
YoY Change | 33.71% | 69.63% |
Common Stock | $385.0K | $328.0K |
YoY Change | 27.48% | 8.61% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $193.2M | $187.1M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $548.1M | $542.1M |
YoY Change | 1.33% | 2.13% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $6.369M | $995.0K |
YoY Change | 1789.91% | -119.96% |
Depreciation, Depletion And Amortization | $8.288M | $2.447M |
YoY Change | -0.25% | -70.91% |
Cash From Operating Activities | $4.511M | $604.0K |
YoY Change | -67.52% | -86.37% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $6.082M | $4.804M |
YoY Change | 2.56% | 10.9% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $513.0K | $273.0K |
YoY Change | -11.4% | 17.17% |
Cash From Investing Activities | -$5.569M | -$5.648M |
YoY Change | 4.07% | 26.64% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | $1.907M | |
YoY Change | 0.16% | |
Cash From Financing Activities | 134.0K | $5.127M |
YoY Change | -101.85% | -229.76% |
NET CHANGE | ||
Cash From Operating Activities | 4.511M | $604.0K |
Cash From Investing Activities | -5.569M | -$5.648M |
Cash From Financing Activities | 134.0K | $5.127M |
Net Change In Cash | -924.0K | -$791.0K |
YoY Change | -171.02% | -79.02% |
FREE CASH FLOW | ||
Cash From Operating Activities | $4.511M | $604.0K |
Capital Expenditures | $6.082M | $4.804M |
Free Cash Flow | -$1.571M | -$4.200M |
YoY Change | -119.74% | -4258.42% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
30597633 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
30597633 | shares |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
1004000 | usd |
CY2024Q1 | us-gaap |
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
|
127418000 | usd |
CY2023Q1 | us-gaap |
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
|
116051000 | usd |
CY2024Q1 | us-gaap |
Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
|
5934000 | usd |
CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
|
5888000 | usd |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
51090000 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
46077000 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
41189000 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
42823000 | usd |
CY2024Q1 | us-gaap |
Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
|
1557000 | usd |
CY2023Q1 | us-gaap |
Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
|
2076000 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
343000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
480000 | usd |
CY2024Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2447000 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
2525000 | usd |
CY2024Q1 | mg |
Acquisition Related Costs And Fair Value Adjustments To Initial Purchase Price Allocation
AcquisitionRelatedCostsAndFairValueAdjustmentsToInitialPurchasePriceAllocation
|
1000 | usd |
CY2023Q1 | mg |
Acquisition Related Costs And Fair Value Adjustments To Initial Purchase Price Allocation
AcquisitionRelatedCostsAndFairValueAdjustmentsToInitialPurchasePriceAllocation
|
3000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5553000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1830000 | usd |
CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
4430000 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
4068000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1123000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5898000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
119000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-920000 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
1004000 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-4978000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
9000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
8000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
995000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4986000 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.17 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.17 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30680000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30021000 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
31356000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
30021000 | shares |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
1004000 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-4978000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-4229000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
1273000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-3225000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-3705000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
9000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
8000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3234000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-3713000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
190503000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-4229000 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1228000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
-1041000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
187465000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
198749000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1273000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1877000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
-773000 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
1004000 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-4978000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8381000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8413000 | usd |
CY2024Q1 | mg |
Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
|
144000 | usd |
CY2023Q1 | mg |
Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
|
-1801000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1228000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1877000 | usd |
CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
227000 | usd |
CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
-30000 | usd |
CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
561000 | usd |
CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-219000 | usd |
CY2024Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-15000 | usd |
CY2023Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
315000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
8696000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-3777000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
23000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
1137000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
6593000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
4234000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-1219000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
992000 | usd |
CY2024Q1 | mg |
Increase Decrease In Other Accrued Liabilities And Deferred Liabilities
IncreaseDecreaseInOtherAccruedLiabilitiesAndDeferredLiabilities
|
6905000 | usd |
CY2023Q1 | mg |
Increase Decrease In Other Accrued Liabilities And Deferred Liabilities
IncreaseDecreaseInOtherAccruedLiabilitiesAndDeferredLiabilities
|
-766000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
80000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-248000 | usd |
CY2024Q1 | us-gaap |
Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
|
0 | usd |
CY2023Q1 | us-gaap |
Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
|
938000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
604000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
4433000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4804000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
4332000 | usd |
CY2024Q1 | mg |
Payments To Acquire Intangible Assets And Software
PaymentsToAcquireIntangibleAssetsAndSoftware
|
1117000 | usd |
CY2023Q1 | mg |
Payments To Acquire Intangible Assets And Software
PaymentsToAcquireIntangibleAssetsAndSoftware
|
361000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
273000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
233000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5648000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-4460000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
1409000 | usd |
CY2023Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
1174000 | usd |
CY2024Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
1907000 | usd |
CY2023Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
1904000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
15000000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
27000000 | usd |
CY2024Q1 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
5000000 | usd |
CY2023Q1 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
27100000 | usd |
CY2024Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
1557000 | usd |
CY2023Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
773000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5127000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-3951000 | usd |
CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-874000 | usd |
CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
207000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-791000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3771000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
17646000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
20488000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
16855000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
16717000 | usd |
CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
4029000 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
5112000 | usd |
CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
756000 | usd |
CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1949000 | usd |
CY2024Q1 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
1165000 | usd |
CY2023Q1 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
2800000 | usd |
CY2024Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
3 | segment |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30021000 | shares |
CY2024Q1 | mg |
Incremental Common Shares Attributable To Stock Options Outstanding
IncrementalCommonSharesAttributableToStockOptionsOutstanding
|
250000 | shares |
CY2023Q1 | mg |
Incremental Common Shares Attributable To Stock Options Outstanding
IncrementalCommonSharesAttributableToStockOptionsOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in prior periods have been reclassified to conform to the current year presentation. Such reclassifications did not have a material effect on the Company's financial condition or results of operations as previously reported.</span></div> | |
CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.106 | |
CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.156 | |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
|
P1Y | |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
184442000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
168016000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
184442000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
168016000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
2900000 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
3100000 | usd |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
250000 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
5.36 | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
0 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
0 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
0 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
250000 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
5.36 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
0 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0 | |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
995000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4986000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30680000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30021000 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.17 | |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
995000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4986000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
30680000 | shares |
CY2024Q1 | mg |
Incremental Common Shares Attributable To Restricted Stock Units Outstanding
IncrementalCommonSharesAttributableToRestrictedStockUnitsOutstanding
|
426000 | shares |
CY2023Q1 | mg |
Incremental Common Shares Attributable To Restricted Stock Units Outstanding
IncrementalCommonSharesAttributableToRestrictedStockUnitsOutstanding
|
0 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
31356000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
30021000 | shares |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.17 | |
CY2024Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
1000 | usd |
CY2023Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
3000 | usd |
CY2024Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
0 | usd |
CY2023Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
0 | usd |
CY2024Q1 | mg |
Acquisition Related Costs And Fair Value Adjustments To Initial Purchase Price Allocation
AcquisitionRelatedCostsAndFairValueAdjustmentsToInitialPurchasePriceAllocation
|
1000 | usd |
CY2023Q1 | mg |
Acquisition Related Costs And Fair Value Adjustments To Initial Purchase Price Allocation
AcquisitionRelatedCostsAndFairValueAdjustmentsToInitialPurchasePriceAllocation
|
3000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
142245000 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
|
134495000 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1841000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
1648000 | usd |
CY2024Q1 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
140404000 | usd |
CY2023Q4 | us-gaap |
Receivables Net Current
ReceivablesNetCurrent
|
132847000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
36500000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
18500000 | usd |
CY2024Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
5974000 | usd |
CY2023Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
6099000 | usd |
CY2024Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
1003000 | usd |
CY2023Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
839000 | usd |
CY2024Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
5495000 | usd |
CY2023Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
5740000 | usd |
CY2024Q1 | us-gaap |
Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
|
2607000 | usd |
CY2023Q1 | us-gaap |
Inventory Supplies Net Of Reserves
InventorySuppliesNetOfReserves
|
2605000 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
15079000 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
15283000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
321384000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
|
319756000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
241682000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
|
238784000 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
79702000 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
|
80972000 | usd |
CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
6500000 | usd |
CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
6300000 | usd |
CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
187354000 | usd |
CY2024Q1 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-1628000 | usd |
CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
185726000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
187815000 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
145155000 | usd |
CY2024Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
42660000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
188835000 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
144841000 | usd |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
43994000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
1900000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
2100000 | usd |
CY2024Q1 | mg |
Accrued Salaries Wages And Employee Related Benefits Current
AccruedSalariesWagesAndEmployeeRelatedBenefitsCurrent
|
28373000 | usd |
CY2023Q4 | mg |
Accrued Salaries Wages And Employee Related Benefits Current
AccruedSalariesWagesAndEmployeeRelatedBenefitsCurrent
|
27372000 | usd |
CY2024Q1 | mg |
Accrued Workers Compensation And Health Benefits Current
AccruedWorkersCompensationAndHealthBenefitsCurrent
|
3590000 | usd |
CY2023Q4 | mg |
Accrued Workers Compensation And Health Benefits Current
AccruedWorkersCompensationAndHealthBenefitsCurrent
|
4385000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
9244000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
7136000 | usd |
CY2024Q1 | us-gaap |
Multiemployer Plans Withdrawal Obligation
MultiemployerPlansWithdrawalObligation
|
2458000 | usd |
CY2023Q4 | us-gaap |
Multiemployer Plans Withdrawal Obligation
MultiemployerPlansWithdrawalObligation
|
2458000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
10743000 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
10686000 | usd |
CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
30067000 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
32294000 | usd |
CY2024Q1 | mg |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
84475000 | usd |
CY2023Q4 | mg |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
84331000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
198426000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
190399000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
9464000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
8900000 | usd |
CY2024Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
188962000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
181499000 | usd |
CY2024Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
3 | segment |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
184442000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
168016000 | usd |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
51090000 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
46077000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
5553000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1830000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8381000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
8413000 | usd |
CY2024Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
42660000 | usd |
CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
43994000 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
542127000 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
534776000 | usd |